Autres langues Ovoca Bio plc Irish S.E.

Actions

Cours en clôture Irish S.E. Autres places de cotation 00:00:00 05/02/2024			Varia. 5j.	Varia. 1 janv.
0,01 ^EUR	-.--%		-.--%	-.--%

2021

Ovoca Bio : Result of Extraordinary General Meeting	17/02/21
Ovoca Bio : Ovoca Bio Announces First Patient Enrolled in Phase II Dose Ranging Study Assessing BP-101 for HSDD	01/02/21
Ovoca Bio : Enrolls First Patient in Phase 2 Trial for Hypoactive Sexual Desire Disorder Treatment	29/01/21
Ovoca Bio : Notice of Extraordinary General Meeting	26/01/21
Ovoca Bio : Interim results for the six months ended 30 June 2020	21/09/20
Ovoca Bio : Acquisition of Remaining Minority Shareholding in IVIX LLC	25/03/20
Ovoca Bio : Form of Proxy AGM	28/06/19
Ovoca Bio : Patent news - Israel	07/05/19
Ovoca Bio : US AND EU CLINICAL DEVELOPMENT PLANS	23/04/19
Ovoca Bio : Presents at BIO-Europe Spring® 2019, Vienna	15/04/19
Ovoca Bio : Operational Update and Acquisition of Additional Interest in IVIX	27/03/19
Ovoca Bio : Primary Endpoints Met in Libicore Phase III Study	25/03/19
Ovoca Bio : is pleased to announce that IVIX has signed an agreement with Biopharma Excellence GmbH (Germany)	10/10/18
Ovoca Bio : Interim Results September 28, 2018	28/09/18
Ovoca Bio : Completion of the Acquisition of IVIX	26/09/18
Ovoca Gold : Form of Proxy for EGM	04/07/18
Ovoca Gold : Form of Proxy for AGM	04/07/18
Ovoca Gold : Notice of AGM	04/07/18
Ovoca Gold : Publication of the Annual Report 2017	25/05/18
Ovoca Gold : Results of EGM and AGM	17/08/16

Aucun résultat pour cette recherche